NHS boosts U.K. cancer fund

NHS England said it will provide the Cancer Drugs Fund (CDF) with an additional L160 million ($265.1 million) over two years. The fund is intended to give patients access to drugs that would not otherwise be available on the NHS.

CDF will also now re-evaluate and remove coverage of the least effective cancer drugs. CDF said drugs it deems excessively expensive could be removed from the national list of covered treatments unless their prices are adjusted. The list includes drugs appraised by the U.K.'s NICE but not recommended based on cost-effectiveness, as well as drugs not yet appraised by NICE. ...